Navigation Links
Ajinomoto Health & Nutrition's Amino Acid Division Announces Price Increase
Date:10/5/2018

The Amino Acid Technologies Division of Ajinomoto Health and Nutrition North America, Inc. (AHN), is announcing a 10% price increase across all markets in January 2019.

The global leader in amino acid manufacturing, AHN produces amino acids — the building blocks of protein — for the parenteral nutrition, biopharmaceutical, infant/medical food, supplement and nutrition markets.

Changing market conditions have contributed to an increase in production costs. Causes include:

  • Increase in raw material prices
  • Increase in transportation and energy costs
  • New global pharmacopoeia and regulatory requirements

“Unfortunately, this market situation will continue for the foreseeable future. Ajinomoto remains committed to producing the highest quality amino acids for our customers,” said Mike Lish, Senior Vice President, Amino Science Division.

About Ajinomoto Health & Nutrition North America, Inc.
Ajinomoto Health & Nutrition North America, Inc. is a subsidiary of Ajinomoto Co., Inc., a global manufacturer of high-quality amino acids, seasonings, processed foods, beverages, pharmaceuticals and specialty chemicals. Ajinomoto Co., Inc., was founded in Japan in 1909 and opened its first U.S. office in 1917 and now employs more than 600 personnel in offices and manufacturing facilities in Illinois, Iowa, and North Carolina. The company is supported by the Ajinomoto Group’s global network of research, development, manufacturing and logistics and contributes to significant advances in nutrition and health, creating a better life for all. For more information visit http://www.ajinorthamerica.com

Read the full story at https://www.prweb.com/releases/ajinomoto_health_nutrition_s_amino_acid_division_announces_price_increase/prweb15815395.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Health impact assessments prove critical public health tool
2. Technology transforms health care
3. Quit smoking? Vitamin E may give extra boost to heart health
4. Microscopic dust particles found in underground railways may pose health risk
5. Merck Animal Health announces Vetsulin
6. Health defects found in fish exposed to Deepwater Horizon oil spill
7. Shared Medical Resources, LLC files suit against Histologics, LLC, Womens Health Laboratories and Avero Diagnostics for Willful Patent Infringement
8. UnitedHealth Group grants more than $1 million for the heart of New Ulm project
9. Preordering lunch increases healthy entree selection in elementary schools
10. Toxic waste sites cause healthy years of life lost
11. Magnesium may be as important to kids bone health as calcium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2019)... ... 2019 , ... Orbsen Therapeutics, a biotechnology company focused on ... move its base of operations from the National University of Ireland (NUI) Galway ... in Galway, Ireland. , “With four clinical trials in full swing and the ...
(Date:4/4/2019)... ... 03, 2019 , ... R3 Stem Cell is now offering ... of Excellence. R3 wants patients to feel secure when they make a significant ... Centers that use inferior regenerative biologics, protocols or amounts, R3 provides a safe ...
(Date:3/29/2019)... (PRWEB) , ... March 28, 2019 , ... In the ... not directly prescribe a path for this task. Despite this uncertainty, several manufacturers have ... of today. In the first part of this webinar, learn how analytical similarity is ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... USDM Life Sciences ... life sciences organizations to accelerate innovation and maximize productivity, announces that nearly 100 ... 12 months. , USDM’s Cloud Assurance is a managed subscription service ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society of Gene & Cell ... team, including a new addition to the presidential line of succession, at the ... the Society's leadership team for a three-year term (2019-2021). , All five incoming members ...
(Date:4/8/2019)... ... 08, 2019 , ... US Capital Global Securities , an affiliate of ... in the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline ... hypoactive sexual dysfunction disorder and is ready to begin phase 2b trials. In phase ...
(Date:4/4/2019)... ... 2019 , ... Biomeme, Inc. , a leading manufacturer ... solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called Franklin ™. ... an English chemist and X-ray crystallographer who made significant contributions to the understanding ...
Breaking Biology Technology: